Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein kinase 1.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
08 Oct 2024
Historique:
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 2 10 2024
Statut: ppublish

Résumé

Casein kinase 1δ (CK1δ) controls essential biological processes including circadian rhythms and wingless-related integration site (Wnt) signaling, but how its activity is regulated is not well understood. CK1δ is inhibited by autophosphorylation of its intrinsically disordered C-terminal tail. Two CK1 splice variants, δ1 and δ2, are known to have very different effects on circadian rhythms. These variants differ only in the last 16 residues of the tail, referred to as the extreme C termini (XCT), but with marked changes in potential phosphorylation sites. Here, we test whether the XCT of these variants have different effects in autoinhibition of the kinase. Using NMR and hydrogen/deuterium exchange mass spectrometry, we show that the δ1 XCT is preferentially phosphorylated by the kinase and the δ1 tail makes more extensive interactions across the kinase domain. Mutation of δ1-specific XCT phosphorylation sites increases kinase activity both in vitro and in cells and leads to changes in the circadian period, similar to what is reported in vivo. Mechanistically, loss of the phosphorylation sites in XCT disrupts tail interaction with the kinase domain. δ1 autoinhibition relies on conserved anion-binding sites around the CK1 active site, demonstrating a common mode of product inhibition of CK1δ. These findings demonstrate how a phosphorylation cycle controls the activity of this essential kinase.

Identifiants

pubmed: 39356670
doi: 10.1073/pnas.2415567121
doi:

Substances chimiques

Casein Kinase Idelta EC 2.7.11.1
Casein Kinase I EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2415567121

Subventions

Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : GM14189
Organisme : HHS | NIH | National Institute of General Medical Sciences (NIGMS)
ID : GM107069
Organisme : Ministry of Health -Singapore (MOH)
ID : MOH-000600

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Rachel L Harold (RL)

Department of Chemistry & Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.

Nikhil K Tulsian (NK)

Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.
Merck Sharp & Dohme International GmBH (Singapore), Neuros, Singapore 138665, Singapore.

Rajesh Narasimamurthy (R)

Program in Cancer and Stem Cell Biology, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.

Noelle Yaitanes (N)

Department of Chemistry & Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.

Maria G Ayala Hernandez (MG)

Department of Chemistry & Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.

Hsiau-Wei Lee (HW)

Department of Chemistry & Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.

Priya Crosby (P)

Department of Chemistry & Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.

Sarvind M Tripathi (SM)

Department of Chemistry & Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.

David M Virshup (DM)

Program in Cancer and Stem Cell Biology, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710.

Carrie L Partch (CL)

Department of Chemistry & Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.
Center for Circadian Biology, University of California San Diego, La Jolla, CA 92093.
HHMI, University of California, Santa Cruz, CA 95064.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH